Literature DB >> 2643101

Identification of receptor-binding residues in the inflammatory complement protein C5a by site-directed mutagenesis.

K W Mollison1, W Mandecki, E R Zuiderweg, L Fayer, T A Fey, R A Krause, R G Conway, L Miller, R P Edalji, M A Shallcross.   

Abstract

C5a is an inflammatory mediator potentially involved in a number of diseases. To help define which of its 74 residues are important for receptor binding and response triggering, changes in the amino acid sequence of C5a were introduced by site-directed mutagenesis. Synthetic C5a-encoding genes incorporating point mutations were expressed in Escherichia coli, and the mutant proteins were purified to homogeneity. Modifications of the C5a molecule causing parallel reductions in binding to polymorphonuclear leukocyte membranes and in stimulation of polymorphonuclear leukocyte locomotion (chemokinesis) suggest that carboxyl-terminal residues Lys-68, Leu-72, and Arg-74 interact with the receptor. Substitutions in the disulfide-linked core of C5a revealed involvement of Arg-40 or nearby residues, because potency losses were associated with only localized conformational changes as detected by NMR. Surprisingly, a substitution at core residue Ala-26, which did not alter C5a core structure, appeared from NMR results to reduce potency by causing a long-distance conformational change centered on residue His-15. Thus, at least three discontinuous regions of the C5a molecule appear to act in concert to achieve full potency.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2643101      PMCID: PMC286450          DOI: 10.1073/pnas.86.1.292

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  34 in total

1.  Chemotactic response to human C3a and C5a anaphylatoxins. I. Evaluation of C3a and C5a leukotaxis in vitro and under stimulated in vivo conditions.

Authors:  H N Fernandez; P M Henson; A Otani; T E Hugli
Journal:  J Immunol       Date:  1978-01       Impact factor: 5.422

2.  Molecular aspects of the serum chemotactic factors.

Authors:  C Gerard; D E Chenoweth; T E Hugli
Journal:  J Reticuloendothel Soc       Date:  1979-12

3.  The complement system in host defense and inflammation.

Authors:  M M Frank
Journal:  Rev Infect Dis       Date:  1979 May-Jun

Review 4.  The structural basis for anaphylatoxin and chemotactic functions of C3a, C4a, and C5a.

Authors:  T E Hugli
Journal:  Crit Rev Immunol       Date:  1981-02       Impact factor: 2.214

5.  Amino acid sequence of the anaphylatoxin from the fifth component of porcine complement.

Authors:  C Gerard; T E Hugli
Journal:  J Biol Chem       Date:  1980-05-25       Impact factor: 5.157

6.  Primary structural analysis of the polypeptide portion of human C5a anaphylatoxin. Polypeptide sequence determination and assignment of the oligosaccharide attachment site in C5a.

Authors:  H N Fernandez; T E Hugli
Journal:  J Biol Chem       Date:  1978-10-10       Impact factor: 5.157

7.  The active site of C3a anaphylatoxin.

Authors:  L H Caporale; P S Tippett; B W Erickson; T E Hugli
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

8.  Crystal structure analysis and molecular model of human C3a anaphylatoxin.

Authors:  R Huber; H Scholze; E P Pâques; J Deisenhofer
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1980-09

9.  Demonstration of specific C5a receptor on intact human polymorphonuclear leukocytes.

Authors:  D E Chenoweth; T E Hugli
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

10.  The effects of some antirheumatic drugs on an in vitro model of human polymorphonuclear leucocyte chemokinesis.

Authors:  M J Smith; J R Walker
Journal:  Br J Pharmacol       Date:  1980-07       Impact factor: 8.739

View more
  27 in total

1.  Protein engineering and site-directed mutagenesis. Patents and literature.

Authors:  J S Dordick
Journal:  Appl Biochem Biotechnol       Date:  1990-10       Impact factor: 2.926

2.  Identification of ligand effector binding sites in transmembrane regions of the human G protein-coupled C3a receptor.

Authors:  J Sun; J A Ember; T H Chao; Y Fukuoka; R D Ye; T E Hugli
Journal:  Protein Sci       Date:  1999-11       Impact factor: 6.725

3.  Group B streptococci inactivate complement component C5a by enzymic cleavage at the C-terminus.

Authors:  J F Bohnsack; K W Mollison; A M Buko; J C Ashworth; H R Hill
Journal:  Biochem J       Date:  1991-02-01       Impact factor: 3.857

Review 4.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

5.  Comparative modelling unravels the structural features of eukaryotic TCTP implicated in its multifunctional properties: an in silico approach.

Authors:  Rakesh Kumar; Shweta Saran
Journal:  J Mol Model       Date:  2021-01-07       Impact factor: 1.810

Review 6.  Surface proteins of Streptococcus agalactiae and related proteins in other bacterial pathogens.

Authors:  Gunnar Lindahl; Margaretha Stålhammar-Carlemalm; Thomas Areschoug
Journal:  Clin Microbiol Rev       Date:  2005-01       Impact factor: 26.132

7.  Antagonistic peptides against human anaphylatoxin C5a.

Authors:  Y Kaneko; N Okada; L Baranyi; T Azuma; H Okada
Journal:  Immunology       Date:  1995-09       Impact factor: 7.397

8.  Two-site binding of C5a by its receptor: an alternative binding paradigm for G protein-coupled receptors.

Authors:  S J Siciliano; T E Rollins; J DeMartino; Z Konteatis; L Malkowitz; G Van Riper; S Bondy; H Rosen; M S Springer
Journal:  Proc Natl Acad Sci U S A       Date:  1994-02-15       Impact factor: 11.205

9.  Enhancement of in vivo and in vitro immune functions by a conformationally biased, response-selective agonist of human C5a: implications for a novel adjuvant in vaccine design.

Authors:  Edward L Morgan; Brandon N Morgan; Elisabeth A Stein; Elizabeth L Vitrs; Marilyn L Thoman; Sam D Sanderson; Joy A Phillips
Journal:  Vaccine       Date:  2009-10-15       Impact factor: 3.641

10.  Site-specific mutations in the N-terminal region of human C5a that affect interactions of C5a with the neutrophil C5a receptor.

Authors:  D F Carney; T E Hugli
Journal:  Protein Sci       Date:  1993-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.